Kurzfassung

A randomized multicenter study comparing Pixantrone + Rituximab with Gemcitabine + Rituximab in patients with aggressive B cell Non Hodgkin lymphoma who have relapsed after therapy with CHOP-R or an
equivalent regimen and are ineligible for stem cell transplantation